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Abstract: The principal objective of these multisite studies (Florida, New York, New Jersey: 
epicenters for human immunodeficiency virus [HIV] among women) was to develop and imple-
ment effective combinations of behavioral interventions to optimize the health status of the most 
neglected and understudied population affected by the acquired immunodeficiency syndrome (AIDS) 
epidemic in the United States: poor women of color living with HIV . The two studies enrolled nearly 
900 women randomly assigned to “high intensity” (cognitive–behavioral stress management train-
ing combined with expressive–supportive therapy [CBSM]+ group) or “low intensity” (individual 
psychoeducational program) treatment conditions over a period of 9 years. The initial study of the 
stress management and relaxation training/expressive–supportive therapy (SMART/EST) Women’s 
Project (SWP I) focused on reducing depression and anxiety, as well as improving self-efficacy and 
overall quality of life for women with case-defined AIDS. Findings from this study demonstrated 
the utility of CBSM+ in reducing distress (depression, anxiety) and denial, while improving social 
support, self-efficacy, coping skills, and quality of life. The second study (SWP II), which included 
all women living with HIV , extended these findings by demonstrating that exposure to CBSM+ 
significantly improved the ability of the participants to take advantage of a health behavior change 
program encouraging the adoption and maintenance of healthier lifestyle behaviors (high levels of 
medication adherence, appropriate nutritional intake and physical activity, safer sexual practices, 
and reduced alcohol use/abuse) essential for optimal health in the context of living with HIV. SWP II 
also determined that the intervention program was equally beneficial to less-acculturated segments 
of the affected population (ie, non-English speaking HIV+ women) through the creation of culturally 
and linguistically sensitive Spanish and Creole versions of the program. A third study (SWP III) is 
currently underway to “translate” this evidence-based treatment program into Community Health 
Centers in Miami, New York City, and metropolitan New Jersey.
Keywords: HIV , AIDS, behavior, social support, viral load, quality of life, translating research 
into practice
Introduction
Over the past decade, women in the USA, particularly poor women of minority status, 
have experienced a 20% increase in rates of new human immunodeficiency virus (HIV) 
infections and acquired immunodeficiency syndrome (AIDS) cases;1 28% of all newly 
identified AIDS cases and 30% of HIV diagnoses are women.1,2 Minority women are 
disproportionately represented among HIV cases, with rates (per 100,000 population) 
for African-American and Hispanic females of 56 and 13.3, respectively, compared to 
2.9 for white women.1 Although African-Americans and Hispanics represent 12% and 
15% of the women in the USA respectively, they account for over 80% of all female 
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In 2007, the rate of AIDS diagnoses in New York City 
 (per 100,000 population) was 24.9, of which 52% were Afri-
can American and 30% were Hispanic.2,3 While national data 
are not available for other Black populations, Haitian women 
account for 16% of all HIV cases in women in Miami-Dade 
County, Florida.4
Florida and New York are first and second for new HIV 
cases in women, with 38% of new HIV cases and 31% of 
AIDS cases in Florida being female, and with higher rates 
among heterosexuals, women, and African Americans than 
the national average.5 Most women with HIV have contracted 
the virus through heterosexual contact or injecting drugs.6,7
With the increased rates of survival, due in large part to 
the advent of effective antiretroviral therapy (ARV), HIV has 
shifted from a terminal illness to a chronic (but transmissible) 
disease, requiring long-term adherence to pharmacologic 
and behavioral regimens. Delivery of medication adherence-
promoting strategies by primary care clinicians requires the 
integration of effective behavioral/mental health services 
into primary care.8–13
New classes of ARVs continue to dramatically alter the 
progression of disease and associated morbidity and mortality 
in persons living with HIV .14–16 Prevention of HIV transmis-
sion becomes an even greater public health challenge as 
more HIV+ persons continue to be sexually active with both 
HIV- and HIV+ partners.17 ARV therapy has adverse side 
effects, which may also increase the risk for other chronic 
diseases, such as diabetes, metabolic syndrome, hyperlipi-
demia, hypertension, and cardiovascular disease. Therefore, 
to maintain high levels of quality of life (QoL) and to reduce 
the risks of other chronic diseases, health services provided 
for persons living with HIV must also include attention to 
comorbid conditions and associated lifestyle behaviors. 
Effective treatment for this population involves a complex 
set of changes in health-related behaviors, which include 
adjusting to a devastating diagnosis, adhering to daunting 
medication regimens, and modifying their diet, physical 
activity levels, sexual practices, and substance use.18 This 
paper will present a compendium of findings from two 
completed studies demonstrating the effects of behavioral 
interventions designed to promote adjustment in HIV-
infected women of color. Already published results will 
be referenced, while new data will be cited with relevant 
statistical parameters.
The stress management and relaxation training/ 
expressive–supportive therapy (SMART/EST) Women’s 
Program (SWP) (see Figure 1) was designed to enhance QoL 
and improve health status for ethnically diverse, disadvan-
taged women living with HIV . Over the past 10 years, this 
research team has developed, adapted, and tested a multicul-
tural, multilingual “healthy lifestyles” intervention program 
tailored to the needs of this population. The SWP I interven-
tion consists of 10 weekly 2-hour group cognitive–behavioral 
stress management/expressive–supportive therapy (CBSM+) 
intervention sessions. SWP II followed the 10 sessions with 
an additional six weekly Group Healthy Living promotion 
program sessions. The CBSM+ component of the interven-
tion includes a series of exercises designed to: 1) provide 
information on stress responses and coping; 2) teach anxiety 
reduction skills (ie, progressive muscle relaxation, deep 
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Figure 1 stress management and relaxation training/expressive-supportive therapy (sMArT/esT) Women’s Program (sWP) theoretical model. copyright © 1999, 
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breathing and guided imagery, autogenic suggestion,   physical 
activity); 3) modify maladaptive cognitive appraisals using 
cognitive restructuring, reframing strategies, and disputing 
irrational beliefs; 4) enhance interpersonal conflict resolution 
skills and anger management via negotiation skills training; 
5) encourage participants to use active, problem-solving 
coping   strategies rather than passive,   emotion-based coping, 
where appropriate; 6) provide a supportive group environ-
ment for the open expression of feelings and thoughts;   
7) increase utilization of social support networks, as well 
as appropriate health care and community resources; and   
8) increase knowledge, change attitudes, and improve adher-
ence to the healthy living components.
The CBSM+ component also includes gender, lan-
guage, and culture-relevant CBSM training (eg, cultural 
issues related to relationships, illness, and health care), 
self-management techniques (eg, learning to recognize 
antecedents of conflict and to control impulses to engage 
in maladaptive and unproductive coping responses), and 
assertiveness training (eg, role-playing appropriate com-
munication strategies), presented within an EST frame-
work. The Group Healthy Living component includes 12 
contact hours focused on medication adherence, nutrition, 
safer sex, substance abuse reduction, and physical activity. 
The intervention is fully manualized and deliverable as a 
16-session program using the CBSM+ framework embed-
ded in the didactic portion to support the Group Healthy 
Living component.
These studies evaluated whether an empirically validated 
depression reduction and stress management intervention 
which had demonstrated efficacy with highly educated gay 
men with AIDS,19 could be successfully adapted to the needs 
of low income minority women. We sought to determine 
whether CBSM+ could impact QoL and overall health status 
of low income, minority women living with HIV by compar-
ing CBSM+ to an   individually delivered psychoeducational 
intervention. This paper   summarizes these findings from the 
first two SWPs (SWP I and SWP II).
Methods
SWP I implemented the program in two venues: a medical 
school setting using university-based clinicians (Miami), 
and in Community Health Centers (CHCs) supported by 
the Health Resources and Services Administration (HRSA), 
using “imported” contracted university-based clinicians 
(metropolitan New York/New Jersey [NY/NJ]).
SWP II was designed to generalize the findings of 
SWP I to a broader population by expanding the inclusion 
criteria to all women infected with HIV (not just women 
with case-defined AIDS), including those with current 
substance abuse and with decreased cognitive functioning. 
SWP II also included women who spoke English, Spanish, 
or Haitian Creole as their principal language. SWP II tested 
the hypothesis that participants who acquired the CBSM+ 
skills would gain more from a health promotion   intervention 
(Group Healthy Living) than those who did not acquire 
these skills.
recruitment
Recruitment for SWP I began in February 1997, and recruit-
ment for SWP II was completed by August 1, 2005. Across 
both trials, 933 study participants were enrolled from Miami, 
New York, and New Jersey. In SWP I, 451 women were ran-
domized to either the CBSM+ group intervention (n = 212) 
or an individual psychoeducational (ie, high-quality “usual 
care”) condition (n = 239). Participants included English-
speaking women who were aged 18 years or older and who 
met the Centers for Disease Control and Prevention (CDC) 
guidelines for case-defined AIDS. Follow-up included post-
treatment, 6-month, and 12-month assessments.
For SWP II, participants (n = 482) consisting of HIV+ 
women who spoke English (n = 237), Spanish (n = 185), or 
Haitian Creole (n = 60), were randomized to receive 10 sessions 
of either a CBSM+ group intervention or the individual psy-
choeducational condition. This was followed by a second 
randomization in which participants received six additional 
sessions of either Group Healthy Living or Individual Health 
Promotion. Assessments were administered at baseline and 
repeated at post-intervention, 6, 12, and 24 months.
In the initial study (SWP I), participation was limited to 
women with CDC case-defined AIDS (CD , 200 or $ 2 
opportunistic infections). Subsequent studies (SWP II and 
SWP III) included all women diagnosed with HIV . Partici-
pation in the study was voluntary, and all participants were 
compensated for time, childcare, and transportation expense 
($25 per session). Of those potentially eligible, approximately 
one third agreed to participate.
screening
structured clinical interview – DsM-IV (scID)
Following recruitment, subjects were screened for speci-
fied DSM-IV (Diagnostic and Statistical Manual of Mental 
Disorders, 4th Edition) psychiatric disorders by PhD level 
psychologists using the Structured Clinical Interview for 
DSM-IV20 adapted for use with nonpatient participants with 
HIV infection (SCID-NP-HIV).21 Specific modules from International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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Table 1A Psychosocial outcome measures
Assessment Author Constructs measured
Depressed affect and anxiety
Beck Depression Inventory (BDI) Beck et al49 Depression
structured clinical Interview for DsM-III-r (scID) First et al20 current depression 
Depression symptoms and HIV/AIDs symptoms differentiation
speilberger state-Trait Anxiety Inventory (sTAI) spielberger et al50 Anxiety
AIDS-specific distress
Impact of events scale (Ies) Horowitz et al51 Intrusion subscale: experiences of daydreams, unwanted images, 
and dreams associated with stressor. 
Avoidance subscale: awareness of distraction from ideas, 
feelings, or situations surrounding stressor.
Quality of life
Medical Outcome study (MOs) Wu et al52 HIV specific questions measuring multiple dimensions of health 
and wellbeing.
Abbreviations:  AIDS,  acquired  immunodeficiency  syndrome;  DSM-III-R,  Diagnostic  and  Statistical  Manual  of  Mental  Disorders,  Third  edition,  revised;  HIV,  human 
immunodeficiency virus.
this interview were used to evaluate current (within the past 
3 months) and lifetime psychotic and mood disorders.
Drug and alcohol abuse and dependency were measured by 
the SCID-NP-HIV , Drug and Alcohol module. At baseline the 
participant’s history and current abuse/dependency status were 
assessed. At all other time points, current abuse/  dependency 
was assessed since the last time interviewed for this study.
Assessment
The variables assessed in this study were in accordance with 
our conceptual model (Figure 1). We grouped the   measures 
into: 1) screening, 2) primary psychosocial outcome 
  variables (depression, anxiety, AIDS-specific distress, QoL), 
3) Healthy Living primary adherence outcome variables 
(adherence to medication, diet, safer sex, physical   activity, 
substance use/abuse reduction), 4) primary biomedical 
outcome variables (viral load, CD4, CD8, sexually transmit-
ted diseases, and health care utilization), and 5) mediating 
variables (eg, coping, self-efficacy) or moderating variables 
(eg, social support, acculturation) (see Tables 1A to 1E). 
All assessment instruments for SWP II were translated into 
Spanish and Creole, incorporating cultural brokerage theory 
throughout the translation process.22–24
cultural/linguistic translation  
of psychosocial measures
Although the resources necessary for full psychometric 
analyses of all assessment instruments with each of our 
  cultural/linguistic groups were not available, the research team 
addressed issues of reliability, and content and construct valid-
ity in our pilot study to ensure relevance of both assessment 
and intervention protocols for our monolingual Hispanic and 
Haitian participants. Procedures were as follows:
1.  Focus groups comprised of cultural/linguistic experts 
and graduates of earlier intervention groups reviewed 
all assessment instruments and all elements of the inter-
vention for cultural appropriateness and validity (having 
similar meanings in both languages).
2.	 Translated and back-translated all assessments and 
  intervention materials.
3.  Evaluated final translated versions of assessment instru-
ments and intervention materials for conveyance of 
intended meaning.
Upon completion of the translation and back-trans-
lations, less than 10% of the translated items required 
additional adjustments for conveyance of meaning. Once 
these translations and adjustments were complete, it was 
possible to administer the entire battery of assessments 
to women who were monolingual in Spanish or Creole. 
These pilot efforts to ensure cultural appropriateness and 
accurate conveyance of meaning demonstrated high con-
tent validity for our assessment and intervention strategies 
with monolingual participants. In addition, we conducted 
tests of reliability and construct validity on measures of 
distress (the Beck Depression Index [BDI] and the Impact 
of Event Scale) and QoL (Medical Outcomes Study) (see 
Tables 2 and 3).
Intervention
Intervention goals and strategies
One of the principal aims of both studies (SWP I and 
SWP II) was to improve the overall health status and QoL 
for our participants. SWP I determined that low-income 
minority women living with AIDS could benefit from an 
intense 10-week program using CBSM+ to reduce distress 
and improve QoL.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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Table 1C Moderator variables: functional quality of life, acculturation, relationship violence, AIDS-specific coping strategies, cognitive 
functioning, and religiosity
Assessment Author Construct measured
Karnofsky Activities of Daily Living scale (ADL) Karnofsky et al60 Quality of life 
gross functional impairment
szapocznik Behavioral Acculturation and 
Biculturalism scales (sBABs)
szapocznik et al61 
szapocznik et al62 
szapocznik and Kurtines63
Level of acculturation to the host culture 
Degree of participation in cultural pluralism
Psychological Acculturation scale (PAs) Tropp et al64 Individual’s perception of cultural identity: psychological 
attachment to culture of origin
cOPe (situational version) carver et al65 Active/Involvement strategies scale: active coping, 
planning, acceptance, seeking emotional support, and 
seeking instrumental support. 
Denial/Disengagement strategies scale: denial, mental 
disengagement, behavioral disengagement.
HIV Dementia scale (HDs) Power et al66 Degree of subcortical HIV dementia via  
memory, attention, psychomotor, and  
construction assessments
Folstein Mini-Mental state exam (MMse) Folstein et al67 Measure of cortical functioning
Abbreviations: AIDS, acquired immunodeficiency syndrome; HIV, human immunodeficiency virus.
Table 1D Mediator variables: self-efficacy and social support
Assessment Author Construct measured
Self-Efficacy Inventory (SEI)  Ironson et al68 
Hinkle et al69
Perceived efficacy to manage future HIV/AIDS 
symptoms and stressors via cBsM strategies
social support Questionnaire (ssQ) sarason et al70 Perceived quantity and quality of emotional and 
personal support
Abbreviations: AIDS, acquired immunodeficiency syndrome; CBSM, cognitive–behavioral stress management; HIV, human immunodeficiency virus.
Table 1B Health behavior outcome measures
Assessment Author Construct measured
Adherence to antiretroviral medication
Adherence to Medication scale (AMs) chesney et al53 Adherence to antiretroviral medication
Sexual risk behavior
Adult sexual risk Behavior Assessment
schedule (serBAs)
Meyer-Bahlburg et al54 sexual risk and IV drug use factors for HIV 
transmission
Sexual barrier use
Barrier Method Questionnaire UcsF cAPs Barrier Questionnaire; 
Family Health International55
Women’s motives and preference for sexual 
barrier use
Nutrition
rapid eating and Activity Assessment for 
Patients (reAP-s)
gans et al56 Food group adequacy and excess
Physical activity
stanford 7-day Activity recall (7-Dr) sallis et al57 Physical activity specific to 7 days prior to 
administration of assessment
Alcohol use
Miami Alcohol Use Questionnaire Ironson (Unpublished)58 Current use, frequency, and amount  
of alcohol
Drug use
Adult sexual risk Behavior Assessment 
schedule (serBAs)
Meyer-Bahlburg et al54 sexual risk and IV drug use factors for HIV 
transmission
scID-nP-HIV Drug Use Dependency Module First et al20 Current use, frequency, and amount of  
drug use
Health care utilization
social service and Utilization schedule (ssUs) Kaminsky et al59 social service and Utilization schedule (ssUs)
Abbreviations: HIV, human immunodeficiency virus; IV, intravenous.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
68
Weiss et al
SWP II expanded the intervention to determine whether 
exposure to the CBSM+ intervention would significantly 
improve the adoption and maintenance of HIV-relevant 
health behaviors (“Healthy Living”). The intervention was 
structured to establish a CBSM-based problem solving and 
coping strategy skill foundation to which HIV-specific health 
promotion Healthy Living issues were added, ie, medica-
tion adherence, nutrition, safer sex, physical activity, and 
substance use/abuse risk reduction.
To test the efficacy of this approach in SWP II, we 
employed a two-stage factorial design in which eligible 
participants were randomized to a 10-week session “high 
intensity” CBSM+ group condition or a 10-week session “low 
intensity” individual psychoeducational condition (ie, high-
quality “usual care”) consisting of educational videos and 
written handout materials similar in informational content 
to the group condition. Following completion of the first 10 
weeks, participants were randomized by group or cohort to a 
six-biweekly session “high intensity” Group Healthy Living 
condition or a “low intensity” Individual Health Promotion 
condition of similar length and content, using educational 
videos and written handout materials. These four conditions 
Table 2 comparative cultural construct validity outcome measures
Outcome measure English Spanish and   
Creole
Pearson r Pearson r
Beck Depression Inventory 0.80 0.93
Impact of events scale (total) 0.90 0.87
Medical Outcomes survey (total) 0.70 0.70
Table 3 comparative cultural internal reliability
Outcome measures English Spanish and   
Creole
Cronbach’s  
alpha
Cronbach’s  
alpha
Beck Depression Inventory  
and state Trait Anxiety 
Inventory/Trait (total)
0.61 0.69
Beck Depression Inventory  
and state Trait Anxiety 
Inventory/state (total)
0.51 0.71
Beck and Impact of events  
scale (total)
0.34 0.59
Beck and Medical Outcomes  
survey (total)
-0.55 -0.71
Table 1E Biomedical outcome measures
Assessment Author Construct measured
Viral load
reverse Transcriptase Polymerase chain reaction  
Amplicor HIV Monitor Ultra-sensitive Kit Assay
Winters et al71 Quantitate blood HIV-1 rnA levels
CD4 and CD8 cell counts
Color flow cytometry Kidd and nicholson72 number and percent of T cells and subsets 
using monoclonal antibodies
Sexually transmitted diseases
Polymerase chain reaction amplification technology Burczac et al73 Detection of Chlamydia trachomatis and 
Neisseria gonorrhea
syphilis rPr Public Health service74 Rapid detection and quantitative 
determination of syphilis in serum or plasma
Anthropometric measures
Height, weight, body mass index, waist–hip ratio, upper arm  
and thigh circumference, height-for age, and weight-for-height  
measurements
nutrition and physical activity tracking
Bio-electrical impendance analysis  
Tanita Body composition Analyzer TBF 300A
segal et al75  
coodley et al76
Measures percentages of body cell mass 
made of water and fat
Abbreviations: HIV, human immunodeficiency virus; RNA, ribonucleic acid; RPR, rapid plasma reagin.
allowed us to test in a well controlled design, the relative value 
of the CBSM+ intervention and the Group Healthy Living 
condition, individually and in combination, for changing 
behaviors relevant to optimal health as compared with less 
intense, more typical “usual care” conditions.
The primary goals of the first 10 sessions were to: 
1) provide participants with information on stress responses 
and coping; 2) teach anxiety reduction skills such as pro-
gressive muscle relaxation and guided imagery; 3) modify 
maladaptive cognitive appraisals using cognitive restructuring 
and reframing strategies;25 4) enhance interpersonal conflict 
resolution skills and anger management via negotiation skills 
training; 5) encourage participants to use active, problem-
solving coping strategies rather than passive, emotion-based 
coping, where feasible; 6) provide a supportive group environ-
ment for the open expression of feelings and thoughts; and International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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7) increase utilization of social support networks. The primary 
goals of Healthy Living were to increase knowledge, change 
attitudes and improve adherence concerning 1)   medication 
regimens, 2) nutritional intake, 3) safer sex, 4) physical activ-
ity, and 5) substance use/abuse risk reduction.
Participants differed in preferred coping style and per-
ceived stressor controllability.26 Therefore, during the first 
10 weeks, participants identified those CBSM techniques 
(from a wide variety offered) that were most helpful and 
suited their own circumstances most closely. During the 
Healthy Living component, participants had the opportunity 
to apply specific CBSM techniques to the adoption and main-
tenance of the aforementioned behaviors related to improving 
health and QoL, as well as reducing HIV transmission.
cultural adaptation of the intervention
Extensive changes were made to the intervention to make 
it more suitable for minority women who principally spoke 
English, Spanish, or Haitian Creole. As our participants 
were predominantly African-American, Haitian-American, 
or Latina women, exercises and examples within the mod-
ules were revised to reflect cultural values; for example, the 
role of familial relationships, spirituality, and the church in 
enhancing social support. A number of exercises previously 
conducted as individual, written in-session exercises were 
modified to reflect the educational level of the majority of 
our participants, and were converted to group oral exercises. 
These adaptations also reflected the cultural values emphasiz-
ing oral rather than written expression, and collective rather 
than individual activities. In addition, the modules incorpo-
rated examples relevant to participants in substance abuse 
recovery; for example, “The Serenity Prayer” was used in the 
coping module to demonstrate the importance of applying 
the appropriate coping responses (emotion-focused versus 
problem-focused) to specific stressors. Every effort was made 
to have at least one of the two female therapists be a member 
of the ethnic groups represented by study participants. Both 
therapists were experienced in working with individuals 
from the relevant ethnic groups to ensure that participants’ 
thoughts, feelings, and behavioral responses to stressors were 
understood within the appropriate cultural context.
A cultural/linguistic working group was responsible 
for tailoring the program to the culture-specific needs and 
issues of our less acculturated English-speaking participants. 
It also was responsible for overseeing the linguistic accuracy 
and equivalence in meaning for all translated materials for 
those HIV+ women who were monolingual in Spanish or 
Creole. In addition to translation and back-translation of 
all materials, the cultural/linguistic working group engaged 
in a “cultural brokerage” process, whereby the contextual 
material from our pilot studies of monolingual Spanish- and 
Creole-speaking groups, plus focus groups and ethnographic 
interviews, was carefully reviewed to ensure that culture-
specific values, mores, and perspectives were integrated into 
the intervention process and content.
Intervention format
CBSM+ was a 10-session, closed, structured group interven-
tion, meeting once weekly for approximately 135 minutes per 
session over a period of 10 weeks. The CBSM+ intervention 
provided an EST environment within which participants were 
trained in CBSM techniques. The intervention sessions were 
modified by participant and therapist feedback, increasing the 
EST component to respond to participant needs to focus on 
HIV themes; for example, mortality, HIV stigma, spiritual-
ity, and cultural issues. The informational component of the 
CBSM+ intervention focused on learning to cope with daily 
stressors associated with HIV-related health problems and 
learning about social resources. In tailoring this group interven-
tion for the target populations, we were acutely aware of the 
importance of maximizing the cultural appropriateness of our 
treatment aims and strategies for all participants. The cultural/
linguistic planning group was charged with the responsibility 
for addressing these issues in all phases of the program.
The development of the Healthy Living component of 
the SWP II intervention was based upon the acknowledged 
importance of a variety of health-enhancing behaviors rel-
evant to maintaining optimal health for persons living with 
HIV. It consisted of six group sessions meeting biweekly 
for approximately 150 minutes per session over a period of 
12 weeks. The sessions included five modules: medication 
adherence, nutrition, safer sex, physical activity, and sub-
stance use/abuse reduction, in video, didactic, and interactive 
formats. The Healthy Living intervention addressed specific 
HIV-related health behaviors and included relevant discus-
sion material and problem-solving exercises; for example, 
memory aids to increase medication adherence, safer sex 
strategies, and techniques to enhance nutritional status and 
levels of physical activity.
The Healthy Living intervention focused on barriers to 
using medication and implementing behavioral solutions 
to increase adherence, social support, and coping with side 
effects and medication concerns. Additionally, the impor-
tance of nutrition in improving and maintaining the health 
of persons living with HIV was discussed, as well as the 
impact of certain types of foods on ARV medications. Also International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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considered were cultural preferences and local availability of 
produce when discussing changing food choices, preparation 
methods, portion sizes, and using foods that were available 
within the local markets rather than replacing foods or using 
unfamiliar ingredients.
The intervention also focused on the correct way to use 
sexual barrier products (male and female condoms) and a 
review of the New York Hierarchy of sexual risk reduction.27 
Participants were supplied with sexual barrier products and 
low-literacy level printed materials, and were given didactic 
information and experiential training in the use of sexual 
barrier products with anatomical models. Participants also 
learned about the health and social effects of recreational 
drugs, alcohol, and smoking on HIV medication, disease 
progression, and health using a brief videotape to stimulate 
group discussion. Finally, the physical activity component 
emphasized the importance of aerobics, strength training, 
and flexibility to increase their activity levels.
The first three sessions of Healthy Living were informa-
tion intensive and focused on health behavior acquisition, 
practice, and maintenance; the fourth and fifth sessions 
emphasized relapse prevention skills. The final session 
summarized the Healthy Living material and applied CBSM 
strategies to incorporating the health behavior messages, 
eg, problem solving, cognitive restructuring, and coping 
strategies.
Individual (attention control) condition
In designing these studies, the research team was faced with 
a serious ethical dilemma: whether to include a “true” control 
condition that would have no discernible health benefit for 
the participants. Due to the fragile health status of the study 
population, it was agreed that no true “placebo” would be 
used, and that both the “group” and “individual” conditions 
would be considered “active”, ie, intended to convey clinical 
benefit. The research team felt that under these circumstances 
it would be appropriate to vary the intensity of the program, 
keeping exposure to the health-enhancing information 
equivalent with differing modes of delivery.
In both SWP I and SWP II, each participant in the indi-
vidual condition was invited to attend a weekly appointment 
of equal length to the group session, during which time the 
participant viewed videotapes related to stress management/
relaxation training and coping with HIV . A professional staff 
member was available to answer questions during the session. 
The informational/educational videos were supplemented 
with entertainment videos to adhere to the similar “attention” 
time requirement (135 minutes). Participants randomized to 
the individual condition selected and viewed an entertainment 
video film each session (after the designated informational/
educational video) to match the time period of the group 
condition and to maintain motivation for continued partici-
pation in the study.
study hypotheses
In both SWP I and SWP II using “intent-to-treat” analyses, 
the group condition was compared with an Individual 
Health Promotion condition.1 Benefit was expected as a 
result of exposure to either condition, with the experimental 
hypotheses favoring the more time- and cost-efficient group 
condition.27 Consistent with this rationale, we conducted 
subgroup analyses which considered “pre–post” treatment 
differences in both conditions in addition to the traditional 
condition × time analyses. We also identified subgroups 
within the larger sample, eg, participants who at study entry 
were more depressed, or were low medication adherers, high 
sexual risk-takers, or active substance abusers, and followed 
their short- and long-term progress from baseline. Although 
these analyses departed somewhat from traditional clinical 
trial design of “intent-to-treat”, we believe the ethical issues 
involved justified the attenuation of study design rigor.
For SWP II, it was hypothesized that exposure to the 
CBSM+ group intervention would provide a more supportive 
environment for an intensive HIV-related health behavior 
change program devoted to maintaining optimum health in 
the long-term management of HIV . Specifically, participation 
in the groups, facilitated by experienced group leaders was 
hypothesized to promote increased medication adherence, 
improved nutritional practices, greater utilization of safer 
sexual practices, more vigorous physical activity patterns, 
and reduced substance abuse as compared with the “equal 
information” individual condition. Using a full factorial 
design enabled us to determine whether CBSM+ significantly 
improved adherence to any or all of the health-related behav-
iors addressed in this study and how a standard educational/
informational experience in CBSM+, Healthy Living, or both, 
compared with one or both sessions of group experience.
Results
The following previously published and original findings 
contained in this paper are from two consecutive studies from 
the SWP I (1996–2000) and SWP II (2001–2006) projects.
general analytic approach
Traditional repeated measures analyses of variance 
(RMANOVA) were used to test the effectiveness of the International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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CBSM+ group intervention during SWP I. For SWP II, 
multilevel models (MLMs) using MLwin 2.028–30 with three 
levels (treatment group, language, time) were fitted for each 
outcome to adjust for the intraclass correlations which may 
result when subjects are nested within sites and subjects were 
measured repeatedly over time. The three-level   models were 
equivalent to a two-by-two analysis of covariance (ANCOVA) 
with the first main factor representing the initial intervention 
and the second main factor representing the health promo-
tion intervention. The term T (time in months since baseline 
examination) and its interactions describe the overall trend 
(slope) of the four groups over the course of the study. In the 
MLM analyses reported here, lines were fitted to the data for 
each outcome in each of the four intervention groups and also 
for two groups which permitted contrasts between participat-
ing in any group condition versus the individual condition for 
the entire 16-week intervention period. Approximate P-values 
for each coefficient and calculated slope were determined by 
Wald’s test and Chi-square tests. Deviance tests were used to 
assess overall improvement as additional terms were intro-
duced into the model. Each outcome was modeled separately 
and a residuals analysis was conducted.
The slopes of these lines were interpreted as the average 
rate of change for the intervention group over the 24-month 
follow-up period. When appropriate, the outcome variables 
were mathematically transformed or data from specified 
subgroups of study subjects were analyzed separately. These 
models provided estimates of the intercept and slope of a line 
fitted to the data in each of the four randomized intervention 
groups, and analyses estimated the effect of receiving any form 
of group intervention versus individual condition. Participants 
were followed for up to 12 months in SWP I and for 24 months 
in SWP II. The overall attrition rate for both studies was 
approximately 20%. All results are reported here as significant 
( P , 0.05; unadjusted for multiple comparisons).
Quality of life
sWP I
Results of the two (condition: group versus individual) by two 
(time: pre- versus post-intervention) RMANOVAs revealed 
significant effects for time for the total QoL score, cognitive 
functioning, health distress, and overall health perceptions, 
such that women in both conditions improved over the course 
of the study. In addition, a significant group by time interac-
tion was noted for mental health QoL such that participants 
in the CBSM+ group showed a significant increase in QoL 
from pre- to post-intervention, whereas individual condition 
participants showed no such change.31
sWP II
Overall, the slopes revealed that there was a significant 
increase in mental health QoL for participants who received 
any group treatment (P , 0.05), and no significant increase 
for individual condition participants.
Depression and anxiety
sWP I
Acquisition of CBSM+ skills was associated with decreased 
symptoms of depression and anxiety (P , 0.05).32 We 
also identified intervention effects on a subgroup of 
154 women who presented with clinically elevated depres-
sion. A RMANOVA (using SAS PROC MIXED; SAS 
Institute, Cary, NC) revealed a significant condition by time 
interaction for both BDI total and the somatic subscale.   
A “within condition” simple effects ANOVA demonstrated 
a significant decrease in both the CBSM+ group condition 
and individual condition for BDI total, and somatic and 
cognitive subscales.32 Across treatment conditions, perceived 
changes in the acquisition of cognitive behavioral skills (as 
assessed by the cognitive-behavioral self-efficacy [CB-SE] 
scale) were associated with reduction in depression. How-
ever, the effects were greatest for those who participated 
in the CBSM+ group, suggesting that learning in context 
with others produces a more   effective outcome. In addition, 
there was a significant inverse interaction between changes 
in CB-SE and depression, as well as anxiety, regardless of 
condition assignment.33 For CBSM+ only, increases in CB-SE 
were significantly correlated with decreases in both BDI 
(r = -0.263) and state anxiety (r = -0.361) scores.
sWP II
Group interventions also significantly reduced depression for 
moderately depressed participants (P , 0.01), significantly 
increased mental health QoL (P , 0.05), and significantly 
decreased log viral load (VL) only in the CBSM+ group 
condition (P , 0.01). Furthermore, SWP II significantly 
improved dietary behaviors,34 reduced sexual risk,35 and 
reduced alcohol usage (P , 0.05).
We also replicated the intervention effects on subgroups 
of depressed women in SWP II. The analyses examined 
the main effects of time, treatment, and the group by time 
interaction, and follow-up analyses examined the degree to 
which the slope for each condition differed from zero. The 
analyses were conducted for both the entire sample (n = 482) 
and for those participants who were moderately depressed at 
baseline (BDI score . 10, n = 245). None of the four groups 
differed in any of the depression scores at baseline. The data International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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revealed a significant effect of time on all three depression 
scores (BDI total, BDI somatic, BDI cognitive) (P , 0.05). 
Across the entire sample, the slope is significantly less than 
zero indicating that there is an overall decline of BDI total 
with time of 0.026 per month. Among those with moderate 
depression (BDI . 10), there is an overall decline in slope 
over time of about 0.146 per month for those in the most 
distressed state. The slopes for those moderately depressed 
participants who had received any group-based intervention 
differed significantly from zero over 24 months (P , 0.01); 
depressed individual condition participants did not change 
significantly over the same time period.
Medication adherence
sWP I
For those women who reported low ARV adherence (, 90%) 
at baseline, self-reported adherence revealed a significant 
increase over baseline in adherence for the CBSM+ group 
(t [44] = 3.08, P , 0.01). In a RMANOVA, the main effect 
of condition (CBSM+ group, individual) by time (pre- and 
post-intervention) was significant (P , 0.05), with 35% of 
the “low adherers” reporting that they increased their level 
of adherence to 95% or greater.36,37
Additional analyses of the SWP I data examining low 
medication adherence and drug use revealed that former 
drug users who were in recovery demonstrated significantly 
greater gains in medication adherence (P , 0.01) as well 
as reduced viral load (P , 0.01) as compared with current 
users or “never” users as a result of participation in the 
intervention.38
sWP II
The slopes revealed that participants with less than 90% 
adherence at baseline increased medication adherence 
significantly in both the CBSM+ group and individual con-
dition (P , 0.01). Participants in the any group condition 
had an increase in ARV adherence, in contrast to the indi-
vidual condition (P , 0.05). Group participants increased 
their emotion-focused coping skills related to adherence 
(P , 0.05) and reported a decrease in the number of reasons 
for missing doses and maintenance of positive medication-
related beliefs.36–38
HIV viral load
sWP I
There were no significant main effects of treatment and no 
significant treatment by time interaction on VL. Follow-up 
analyses examined the effects of treatment group and changes 
in CB-SE skills acquired during treatment on changes in 
VL and CD4 cell count. For the CBSM+ group, increases 
in CB-SE were significantly correlated with decreases 
in VL over time (post-intervention, r = -0.284; 6-month 
follow-up, r = -0.418; 12-month follow-up, r = -0.275; all 
P , 0.05). Increases in AIDS self-efficacy (AIDS-SE) were 
also significantly correlated with increases in CD4 cell count 
at post-intervention (r = 0.269; P , 0.05), although this 
improvement was not maintained at follow-up. These results 
suggest that improving self-efficacy is related prospectively 
to both improved disease and health status.39
sWP II
Among the high-risk patients (n = 451) defined as those with 
detectable viral loads at baseline (. 400 copies/mL), VL 
decreased significantly over 24 months only in the CBSM+ 
group condition (P , 0.01) and not in the individual condi-
tion (see Figure 2A). An additional analysis broken down 
by location (Miami versus NY/NJ) demonstrated that VL 
decreases in the group condition were noted in both Miami 
and NY/NJ (P , 0.001), but not in the individual condition 
in either location40 (see Figure 2B). An additional observation 
highlights the relative differences in baseline VLs in Miami 
as compared with New York, suggesting there may be differ-
ent regional treatment strategies, (ie, more aggressive ARV 
treatment in New York), which must be considered in future 
intervention trials.
sexual risk reduction  
and domestic violence
sWP II
At baseline, the mean number of sexual acts was 2.9 ± 2.6 
per week. The mean number of protected acts was 1.4 ± 2.3, 
with 56% of the participants reporting no protected acts. The 
probability of unprotected sex was calculated by dividing 
the number of protected acts by the total number of acts. The 
results of a mixed modeling procedure show that the group 
intervention significantly decreased the unprotected sex odds 
ratio from 0.162 to 0.095 (F [1,220, 122] = 0.04, P , 0.038). 
Group participants also increased use of vaginal sexual barri-
ers with no decreased use of male condoms (P , 0.05).
Alcohol and substance abuse
sWP II
No differences were observed between conditions. 
A   one-way RMANOVA comparing drug and alcohol use 
at three different times: baseline, 6 months, and 12 months 
follow-up demonstrated a significant reduction in alcohol International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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use between baseline and 12 months follow-up in both 
conditions (F [2,486] = 3.39, P , 0.05). No changes were 
noted for drug use.
nutrition
sWP II
A one-way RMANOVA compared the scores of the Rapid 
Eating and Activity Assessment for Patients (REAP) ques-
tionnaire41 (total, sugar, fat, vegetables, fruit). No differences 
were noted at baseline between the conditions. Dietary pat-
terns improved after the nutrition intervention for the entire 
sample and were still significantly better at 24 months post-
baseline. Significant effects (P , 0.05) were found for REAP 
total, sugar, and fat.40 Group participants initially improved 
more than those who did not, but there were no differences 
between conditions by 24 months post-baseline.
Physical activity
sWP II
At baseline, there were no differences in self-reported dura-
tion of daily walking activity between women assigned to 
the group (21 ± 8 minutes/day) or individual (24 ± 7 minutes/
day) conditions. A RMANOVA from baseline to post-
intervention revealed the main effect for time was significant 
(F [2,39] = 12.6, P , 0.01), with women in both conditions 
increasing their walking activity to 62 and 51 minutes/day, 
respectively.
cultural/linguistic effects
Analyses were conducted to determine whether the effects 
of the intervention for Spanish- and Creole-speaking women 
were the same as those for English-speaking women. Overall, 
these analyses suggest that there were no significant differ-
ences among the English- Spanish- and Creole-speaking 
groups with regard to the behavioral and health status 
outcomes. The overall findings indicate that the cultural 
brokerage process and linguistic translations were effective 
in adapting the intervention to the needs of all three cultural/
linguistic groups. See Table 4.
Discussion
The participants in these two studies, nearly 1000 poor, 
predominantly African-American, Hispanic, and Haitian-
American women living with HIV , drawn from three of the 
major epicenters for HIV infection in this country (South 
Florida, New York, and New Jersey), represent seriously 
underserved segments of the United States HIV+ popula-
tion. The primary objective of these studies was to determine 
whether a behavioral intervention strategy previously found 
to be effective with middle-class gay men could be tailored 
to the needs of disadvantaged, ethnically diverse women.
Over the 10-year history of the two studies, dramatic 
improvement of treatment options occurred with the advent of 
combination therapy with ARVs, converting a life-threatening 
disease into a potentially chronic, yet manageable, condition. 
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With the increase in life expectancy among HIV+ patients, 
new challenges have emerged in terms of effective disease 
management for patients living with HIV . The increases in 
survival have been accompanied by new clinical issues, 
including lipodystrophy, increases in cardiovascular risk 
and diabetes,41 and relapses in high-risk behaviors including 
increases in drug use and unsafe sexual practices.42 All of 
these phenomena can be considered as potential stressors, 
and our interventions were designed to provide the skills to 
facilitate adjustment to these contemporary challenges of 
living with HIV .
The overall findings from the two studies suggest that 
the CBSM+ intervention combined with Healthy Living 
components was effective in reducing distress, improving 
QoL, as well as reducing sexual risk, improving medication 
adherence, and reducing alcohol abuse. Pre–post subgroup 
analyses also identified salutary changes in nutrition, VL, 
and physical activity. There were, however, no comparable 
findings for drug abuse; that is, no significant changes in 
drug use/abuse were noted.
Of specific interest is the finding that the intervention 
appeared to be equally effective with less-acculturated 
women who were monolingual in Spanish or Creole. Special 
efforts were made through the “cultural brokerage” process 
to make the content and structure of the sessions consistent 
with the values and mores of the Hispanic and Haitian cul-
tures. For example, issues concerning stigma and disclosure 
were more heavily emphasized in the sessions to reflect their 
importance within these groups.
It must be remembered that our study participants were 
selected on the basis of their HIV status rather than on the 
basis of specific behavioral, psychological, or sociological 
diagnoses or characteristics. Although we anticipated 
that there would be more psychosocial, behavioral, and 
psychiatric problems among our participants based upon 
their HIV infection and socioeconomic status, we also 
  recognized that the majority of participants would not qualify 
as “depressed, anxious, nonadherent, or substance abusing”. 
This was reflected, for example, in the “main effects” analyses 
for depression, where we found no significant effect of the 
intervention on reducing depression for the entire interven-
tion population. However, when we restricted the analysis 
to only those who entered the study moderately depressed, 
then a significant difference was noted in the experimental 
condition as compared with the control condition.
Taking each of the findings in turn, it is notable that only 
a third of our participants qualified as “moderately” depressed 
at study entry. As noted above, severely depressed study 
candidates were temporarily excluded and requested to seek 
treatment prior to becoming eligible for study enrollment. 
Although we found that the intervention significantly reduced 
depression in the intervention versus control condition, 
the generalizability of the finding is limited by the study 
inclusion/exclusion criteria.
Similarly, a minority of our participants were considered 
“nonadherent” with respect to antiretroviral medications. 
Again, the overall “main effects” analysis showed no signifi-
cant improvement in medication adherence in the intervention 
participants. Only when the “low adherers” were identified was 
a treatment outcome noted which demonstrated significant 
improvement in medication adherence for low adherers in the 
intervention condition compared with the control condition.
Table 4 summary of study outcomes
Study and domain SWP I SWP II
QoL Improved QoL, cognitive functioning, health  
distress, overall health perceptions and mental health
Improved QoL mental health
Depression and anxiety Decreased depression and anxiety Decreased depression
Medication adherence Increased ArV adherence Increased ArV adherence among low adherers, increase in 
emotion- focused coping skills related to adherence, and 
decrease in number of reasons for missing dose
VL Increased cB-se skills related to decreases in VL and  
AIDs-se related to increases in cD4 count over time
VL decreased
sexual risk reduction 
and domestic violence
n/A Decreased unprotected sex and increased use of vaginal 
sexual barriers
Alcohol and drug use n/A no changes noted
nutrition n/A Dietary patterns improved for reAP total, sugar, and fat
Physical activity n/A Increased walking activity for minutes/day
Note: These outcomes were not assessed in sWP I.
Abbreviations: AIDS-SE, acquired immunodeficiency syndrome self-efficacy; ARV, antiretroviral therapy; CB-SE, cognitive–behavioral self-efficacy; N/A, not applicable; 
QoL, quality of life; SWP I/II, stress management and relaxation training/expressive-supportive therapy (SMART/EST) Women’s Program – first study/second study; VL, 
viral load.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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Finally, improvements in daily walking were noted 
in both conditions, suggesting that they may have been 
the result of physical ailment relief associated with 
treatment rather than the physical activity aspects of the 
intervention.
These two studies taken together have demonstrated the 
feasibility of implementing a comprehensive group-based 
behavioral and lifestyle intervention to provide services 
to HIV+ women in both academic and community-based 
primary care settings using a CBSM+ framework. The 
study was designed to intervene on a wide range of clini-
cal and psychosocial needs of multicultural HIV+ female 
patients seen in primary care settings, and all components 
of the intervention did not apply to every patient. While 
  intent-  to-treat analyses conducted for all primary and sec-
ondary outcomes did not demonstrate significant group × 
time effects, to evaluate the impact of the intervention on 
specific at-risk patients, subgroups of high-risk patients 
were identified and analyses were repeated with respect to 
the specific outcomes (ARV adherence, condom use, etc). 
The majority of high-risk subgroup analyses conducted 
demonstrated significant improvements in most of the 
interventions, which enhances the feasibility and efficacy of 
delivering group-based behavioral interventions to diverse 
patient populations, and supports widespread dissemination 
and adoption of the protocol.
The significant findings within these clinically important 
subgroups are impressive when compared with the only other 
large-scale intervention study (nonrandomized) in similar 
service settings. In 2004, Landon et al43 assessed the effec-
tiveness of a quality improvement collaborative that focused 
upon improving the quality of care of HIV-infected patients. 
In a rigorously controlled pre- and post-intervention study, 
no significant effect on the quality of care was found. In an 
accompanying article, Mittman11 strongly advised that future 
collaboratives ought to be subjected to thorough evaluation 
to elucidate the conditions that result in best outcomes from 
the intervention.44 He also stated that “researchers must 
recognize the heterogeneity of individual applications of 
the collaborative method and the limited value of conven-
tional synthesis methods that are better suited to clinical 
evidence than evidence in the management, behavioral, 
and social sciences”. These comments emphasize the chal-
lenges of balancing high levels of implementation fidelity 
with flexibility, protocol drift, and local adaptation that may 
happen over time, and the value of subgroup analyses to 
identify those populations most likely to benefit from such 
interventions.
Dissemination: the next frontier
The challenges associated with moving effective interven-
tions from research to practice are substantial and require 
attention to issues including training, treatment fidelity, 
staffing, resource allocation, finance, and reimbursement.43 
Glasgow et al8 have proposed a framework called “RE-AIM” 
(Reach, Efficacy, Adoption, Implementation,   Maintenance), 
which accounts for dimensions for evaluation on the 
individual patient and the adopting organization levels. 
The RE-AIM framework has proposed that the estimate of 
program impact on a population is the product of its reach, 
efficacy, and implementation, while on the organizational 
level; the impact estimate is the product of adoption and 
implementation.46 This approach provides a multilevel 
framework to examining the individual and organizational 
levels of adoption of innovations47 and change.
To that end, a new study funded by the Centers for Disease 
Control and Prevention is underway, training health profes-
sional and allied health care staff to deliver the 16-session 
manualized intervention. Using Glasgow’s RE-AIM model as 
the theoretical basis for translating evidenced-based interven-
tions into health practice, this study is disseminating these 
strategies into community health settings recruited from an 
established national system of primary care: HRSA Primary 
Care and Ryan White grantees. The results of this program 
will have significant implications for the feasibility of the 
integration of the SWP with behavioral and mental health 
services, and improving health outcomes for all women 
  living with HIV .
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